| IDORSIA AG SF-,05 |
| Schweiz |
| Gesundheit |
| CH0363463438 / A2DTEB |
| 19T (Frankfurt) |
| FRA:19T, ETR:19T, 19T:GR |
| - |
| https://www.idorsia.com/ |
|
Idorsia Ltd is a Swiss biopharmaceutical company headquartered in Allschwil near Basel, specializing in the discovery, development, and commercialization of innovative small-molecule medicines for unm..
>Volltext.. |
| 952.53 Mio. EUR |
| 2309.32 Mio. EUR |
| 243.75 Mio. EUR |
| - |
| -123.67 Mio. EUR |
| -0.48 EUR |
| 1482.74 Mio. EUR |
| 98.33 Mio. EUR |
| - |
| - |
| 104.35% |
| 54.84% |
| - |
| - |
| - |
| - |
| IDORSIA |
| 16.03.26 |
|
||||
|
||||
|